Furukawa T - Search Results

1

Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1).

Naito Y, Aburatani H, Amano T, Baba E, Furukawa T, Hayashida T, Hiyama E, Ikeda S, Kanai M, Kato M, Kinoshita I, Kiyota N, Kohno T, Kohsaka S, Komine K, Matsumura I, Miura Y, Nakamura Y, Natsume A, Nishio K, Oda K, Oda N, Okita N, Oseto K, Sunami K, Takahashi H, Takeda M, Tashiro S, Toyooka S, Ueno H, Yachida S, Yoshino T, Tsuchihara K; Japanese Society of Medical Oncology; Japan Society of Clinical Oncology; Japanese Cancer Association. Naito Y, et al. Among authors: furukawa t. Int J Clin Oncol. 2021 Feb;26(2):233-283. doi: 10.1007/s10147-020-01831-6. Epub 2020 Nov 29. Int J Clin Oncol. 2021. PMID: 33249514 Free PMC article.

2

Recessive RYR1 mutations in a patient with severe congenital nemaline myopathy with ophthalomoplegia identified through massively parallel sequencing.

Kondo E, Nishimura T, Kosho T, Inaba Y, Mitsuhashi S, Ishida T, Baba A, Koike K, Nishino I, Nonaka I, Furukawa T, Saito K. Kondo E, et al. Among authors: furukawa t. Am J Med Genet A. 2012 Apr;158A(4):772-8. doi: 10.1002/ajmg.a.35243. Epub 2012 Mar 9. Am J Med Genet A. 2012. PMID: 22407809

3

[No title available]

[No authors listed] [No authors listed] PMID: 37093414

4

Impacts of activation of the mitogen-activated protein kinase pathway in pancreatic cancer.

Furukawa T. Furukawa T. Front Oncol. 2015 Feb 4;5:23. doi: 10.3389/fonc.2015.00023. eCollection 2015. Front Oncol. 2015. PMID: 25699241 Free PMC article. Review.

5

Molecular targeting therapy for pancreatic cancer: current knowledge and perspectives from bench to bedside.

Furukawa T. Furukawa T. J Gastroenterol. 2008;43(12):905-11. doi: 10.1007/s00535-008-2226-1. Epub 2008 Dec 24. J Gastroenterol. 2008. PMID: 19107333 Review.

6

Subtyping of IPMN.

Furukawa T. Furukawa T. Methods Mol Biol. 2019;1882:1-8. doi: 10.1007/978-1-4939-8879-2_1. Methods Mol Biol. 2019. PMID: 30378039

7

Gene Rearrangement and Expression of PRKACA and PRKACB Govern Morphobiology of Pancreatobiliary Oncocytic Neoplasms.

Itoh T, Omori Y, Seino M, Hirose K, Date F, Ono Y, Mizukami Y, Aoki S, Ishida M, Mizuma M, Morikawa T, Higuchi R, Honda G, Okamura Y, Kinoshita K, Unno M, Furukawa T. Itoh T, et al. Among authors: furukawa t. Mod Pathol. 2024 Jan;37(1):100358. doi: 10.1016/j.modpat.2023.100358. Epub 2023 Oct 21. Mod Pathol. 2024. PMID: 37871652

8

Prognostic performance of microscopic size measurements in small invasive carcinomas arising in intraductal papillary mucinous neoplasms of the pancreas.

Zhang ML, Omori Y, Hong SM, Ideno N, Date K, Rocha Castellanos DM, Shroff SG, Zamboni G, Gonzalez RS, Furukawa T, Fernandez-Del Castillo C, Mino-Kenudson M. Zhang ML, et al. Among authors: furukawa t. Histopathology. 2024 Apr 25. doi: 10.1111/his.15198. Online ahead of print. Histopathology. 2024. PMID: 38660970

9

Molecular pathology of pancreatic cancer: implications for molecular targeting therapy.

Furukawa T. Furukawa T. Clin Gastroenterol Hepatol. 2009 Nov;7(11 Suppl):S35-9. doi: 10.1016/j.cgh.2009.07.035. Clin Gastroenterol Hepatol. 2009. PMID: 19896096 Review.

10

The impact of continuity correction methods in Cochrane reviews with single-zero trials with rare events: A meta-epidemiological study.

Tsujimoto Y, Tsutsumi Y, Kataoka Y, Shiroshita A, Efthimiou O, Furukawa TA. Tsujimoto Y, et al. Among authors: furukawa ta. Res Synth Methods. 2024 May 15. doi: 10.1002/jrsm.1720. Online ahead of print. Res Synth Methods. 2024. PMID: 38750630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,800 results

Search Page